
Zomedica Corp. (NYSE American: ZOM)
Interview update with Larry Heaton, CEO and President […]
Interview update with Larry Heaton, CEO and President […]
XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]
Interview with Philip Sassower, Chief Executive Officer and Co-Chairman […]
Interview with Lewis Bateman, CEO
[…]
Company Continues to Build Through Channel Program, Sees Growth in 2023
[…]
Ottawa, Ontario–(Newsfile Corp. – November 22, 2022) – C-COM Satellite Systems Inc., (TSXV: CMI) (OTCQB: CYSNF) a leading global provider of commercial grade mobile auto-deploying satellite antenna systems, announced today that it will open a new R&D […]
Interview with Eric Schlorff, CEO and President […]
Interview with David Roman, CEO […]
Interview with Mark Kay, CEO and Chairman […]
Dr. Evans brings extensive strategic experience to advance search for XRx-008 Phase 3 development and commercialization partner […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com